About us

We are a dynamic, early-stage biotech on a mission to end organ failure, starting with the kidney. Our research into functional proteomics and the root causes behind organ dysfunction is uncovering new biological targets and our novel approach to drug development, assisted by powerful machine-learning programs, is enabling us to develop a number of drugs that specifically target kidney cells to prevent and treat various forms of kidney disease.

Pre-clinical data for our most advanced programs suggest this approach could deliver safe and effective drugs for a number of currently untreatable kidney diseases affecting millions of patient each year.

Our People

Like our approach to drug development, the Atorvia team is well differentiated: world class scientists with backgrounds in industry and academia & industry veterans with successful track records in discovery, translation, clinical development and commercialization. We ensure our cutting-edge science programs incorporate commercial strategies from the onset and start with the end in mind: the patient, the physician, and the payer.

We believe that being unique is powerful, and this applies as much to our people as it does to our strategy, so we are building a company that celebrates diversity and a culture where difference is valued.  Although we are small, we are mighty, and we approach our work fearlessly. A women- and BIPOC- founded and led company, we have an inclusive workplace with a global mindset and welcome brilliant people to join us on our journey who will be themselves.

If you’re driven to perform, you’ll fit right in. Put simply, we hire the best, then let you shine.

If you are interested in Atorvia’s journey and believe you could complement the team, help accelerate and advance our work and make a difference to patients with organ failure, please contact us here.